Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Augusto Lauro, Roberto De Giorgio & Antonio Daniele Pinna. (2015) Advancement in the clinical management of intestinal pseudo-obstruction. Expert Review of Gastroenterology & Hepatology 9:2, pages 197-208.
Read now
Read now
Chong-Zhi Wang & Chun-Su Yuan. (2013) Pharmacologic treatment of opioid-induced constipation. Expert Opinion on Investigational Drugs 22:10, pages 1225-1227.
Read now
Read now
Banny S Wong & Michael Camilleri. (2011) Lubiprostone for the treatment of opioid-induced bowel dysfunction. Expert Opinion on Pharmacotherapy 12:6, pages 983-990.
Read now
Read now
Tisha N Lunsford & Lucinda A Harris. (2010) Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome. International Journal of Women's Health 2, pages 361-374.
Read now
Read now
Shailendra Kapoor. (2010) Emerging New Therapeutic Options for the Management of Opioid Induced Constipation. Journal of Pain & Palliative Care Pharmacotherapy 24:1, pages 98-99.
Read now
Read now
Articles from other publishers (36)
Yuan Li, Haitao Yu, Bing Xu, Fang Yuan, Ping Zhang, Shengqing Tu, Yumeng Zhou & Xin Li. (2023) Pharmacokinetics and Bioequivalence of the Lubiprostone Capsule in Healthy Chinese Subjects. Clinical Pharmacology in Drug Development 12:4, pages 436-446.
Crossref
Crossref
Orhan Atay, Jennie David & Ami Mehta. (2022) A Hypothetical Case Example Illustrating the Importance of a Multidisciplinary Approach to Treating Chronic/Functional Abdominal Pain in Pediatric Patients. Pediatric Clinics of North America 69:5, pages 917-927.
Crossref
Crossref
Marina Fortea, Mercé Albert-Bayo, Mar Abril-Gil, John-Peter Ganda Mall, Xavier Serra-Ruiz, Alejandro Henao-Paez, Elba Expósito, Ana María González-Castro, Danila Guagnozzi, Beatriz Lobo, Carmen Alonso-Cotoner & Javier Santos. (2021) Present and Future Therapeutic Approaches to Barrier Dysfunction. Frontiers in Nutrition 8.
Crossref
Crossref
Ryuichi Kawamoto, Asuka Kikuchi, Daisuke Ninomiya & Teru Kumagi. (2021) Clubbed Digits Presumably Caused by Lubiprostone. Internal Medicine 60:15, pages 2499-2502.
Crossref
Crossref
Danhua Ge, Xin Wang & Xue-Qiang Chu. (2021) Difluoroalkylation/1,2-aryl migration of allylic alcohols under transition metal-free conditions. Tetrahedron Letters 70, pages 153002.
Crossref
Crossref
Mohammed Hasosah. (2021) Chronic Refractory Constipation in Children: Think Beyond Stools. Global Pediatric Health 8, pages 2333794X2110487.
Crossref
Crossref
Marcelo A. Catalán, Francisca Julio-Kalajzić, María Isabel Niemeyer, Luis Pablo Cid & Francisco V. Sepúlveda. (2020) Short Chain Fatty Acids Effect on Chloride Channel ClC-2 as a Possible Mechanism for Lubiprostone Intestinal Action. Cells 9:8, pages 1781.
Crossref
Crossref
Takuya Yumizaki, Mika Maeda, Tomoe Fujita, Hiroyoshi Kakuyama & Yuji Kumagai. (2020) A 3‐Part Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DSP‐6952 in Healthy Japanese Subjects and Those With ≤3 Spontaneous Bowel Movements per Week. Clinical Pharmacology in Drug Development 9:3, pages 353-365.
Crossref
Crossref
Lawrence R Schiller. (2019) Chronic constipation: new insights, better outcomes?. The Lancet Gastroenterology & Hepatology 4:11, pages 873-882.
Crossref
Crossref
Ye Zong, Shengtao Zhu, Shutian Zhang, Gen Zheng, John W Wiley & Shuangsong Hong. (2018) Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor‐mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human. Neurogastroenterology & Motility 31:2, pages e13477.
Crossref
Crossref
John Cuppoletti, Kirti P. Tewari, Jayati Chakrabarti & Danuta H. Malinowska. (2017) Identification of the fatty acid activation site on human ClC-2. American Journal of Physiology-Cell Physiology 312:6, pages C707-C723.
Crossref
Crossref
Hongwei Wang, Minghui Xu, Qingjie Kong, Peng Sun, Fengyun Yan, Wenying Tian & Xin Wang. (2017) Research and progress on ClC-2. Molecular Medicine Reports 16:1, pages 11-22.
Crossref
Crossref
Jakob Lykke Poulsen, Christina Brock, Anne Estrup Olesen, Matias Nilsson & Asbjørn Mohr Drewes. (2015) Evolving paradigms in the treatment of opioid-induced bowel dysfunction. Therapeutic Advances in Gastroenterology 8:6, pages 360-372.
Crossref
Crossref
Vanessa C. Costilla & Amy E. Foxx-Orenstein. (2014) Constipation in Adults: Diagnosis and Management. Current Treatment Options in Gastroenterology 12:3, pages 310-321.
Crossref
Crossref
Supriya Rao & H. Christian Weber. (2014) New treatment targets for the management of irritable bowel syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 21:1, pages 9-14.
Crossref
Crossref
Vanessa C. Costilla & Amy E. Foxx-Orenstein. (2014) Constipation. Clinics in Geriatric Medicine 30:1, pages 107-115.
Crossref
Crossref
Han-Yi JiaoDong Hyun KimJung Suk KiKwon Ho RyuSeok ChoiJae Yeoul Jun. (2014) Effects of Lubiprostone on Pacemaker Activity of Interstitial Cells of Cajal from the Mouse Colon. The Korean Journal of Physiology & Pharmacology 18:4, pages 341.
Crossref
Crossref
Marina A. Gonzalez-Martinez, Nayeli X. Ortiz-Olvera & Jorge Mendez-Navarro. (2014) Novel Pharmacological Therapies for Management of Chronic Constipation. Journal of Clinical Gastroenterology 48:1, pages 21-28.
Crossref
Crossref
Kelly K. Everhart & Brian E. Lacy. 2014. Constipation. Constipation
67
95
.
Scott L. Gabbard & Brian E. Lacy. (2013) Chronic Intestinal Pseudo-Obstruction. Nutrition in Clinical Practice 28:3, pages 307-316.
Crossref
Crossref
D.T. Beattie, D.L. Higgins, M.P. Ero, S.M. Amagasu, R.G. Vickery, K. Kersey, A. Hopkins & J.A.M. Smith. (2013) An in vitro investigation of the cardiovascular effects of the 5-HT4 receptor selective agonists, velusetrag and TD-8954. Vascular Pharmacology 58:1-2, pages 150-156.
Crossref
Crossref
S. Evangelista. 2013. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Ulrike Voß, Anne Lewerenz & Karen Nieber. 2012. Sex and Gender Differences in Pharmacology. Sex and Gender Differences in Pharmacology
473
497
.
Brian E. Lacy, John M. Levenick & Michael Crowell. (2012) Chronic constipation: new diagnostic and treatment approaches. Therapeutic Advances in Gastroenterology 5:4, pages 233-247.
Crossref
Crossref
E. M. M. Quigley. (2012) Commentary: long‐term lubiprostone for constipation predominant IBS. Alimentary Pharmacology & Therapeutics 35:8, pages 962-963.
Crossref
Crossref
Juan F Gallegos-Orozco, Amy E Foxx-Orenstein, Susan M Sterler & Jean M Stoa. (2012) Chronic Constipation in the Elderly. American Journal of Gastroenterology 107:1, pages 18-25.
Crossref
Crossref
Anthony J. Lembo, John F. Johanson, Henry P. Parkman, Satish S. Rao, Philip B. MinerJr.Jr. & Ryuji Ueno. (2011) Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation. Digestive Diseases and Sciences 56:9.
Crossref
Crossref
Joseph Y Chang & Nicholas J Talley. (2011) An update on irritable bowel syndrome: from diagnosis to emerging therapies. Current Opinion in Gastroenterology 27:1, pages 72-78.
Crossref
Crossref
Atul Deodhar & Dawn A. MarcusDawn A. Marcus & Atul Deodhar. 2011. Fibromyalgia. Fibromyalgia
89
100
.
Ursula M. Szmulowicz & Tracy L. Hull. 2011. The ASCRS Textbook of Colon and Rectal Surgery. The ASCRS Textbook of Colon and Rectal Surgery
23
39
.
M. Goldberg, Y.‐P. Li, J. F. Johanson, A. W. Mangel, M. Kitt, D. T. Beattie, K. Kersey & O. Daniels. (2010)
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT
4
agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response study
. Alimentary Pharmacology & Therapeutics 32:9, pages 1102-1112.
Crossref
Crossref
Joseph Y. Chang & Nicholas J. Talley. (2010) Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends in Pharmacological Sciences 31:7, pages 326-334.
Crossref
Crossref
Kenneth A. Jacobson & Jean-Marie Boeynaems. (2010) P2Y nucleotide receptors: promise of therapeutic applications. Drug Discovery Today 15:13-14, pages 570-578.
Crossref
Crossref
Dov Gandell & Shabbir M. H. Alibhai. 2010. Evidence‐Based Geriatric Medicine. Evidence‐Based Geriatric Medicine
140
154
.
Ritu Walia, Lori Mahajan & Rita Steffen. (2009) Recent advances in chronic constipation. Current Opinion in Pediatrics 21:5, pages 661-666.
Crossref
Crossref
Barbara J. Messinger-Rapport, David R. Thomas, Julie K. Gammack & John E. Morley. (2009) Clinical Update on Nursing Home Medicine: 2009. Journal of the American Medical Directors Association 10:8, pages 530-553.
Crossref
Crossref